| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
|
N Engl J Med
|
2011
|
11.93
|
|
2
|
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
|
J Clin Oncol
|
2009
|
3.18
|
|
3
|
Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial.
|
Lancet Oncol
|
2011
|
2.26
|
|
4
|
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.
|
Neuroendocrinology
|
2004
|
2.16
|
|
5
|
Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?
|
Eur J Gastroenterol Hepatol
|
2010
|
1.10
|
|
6
|
Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.
|
Eur J Gastroenterol Hepatol
|
2013
|
1.08
|
|
7
|
Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors.
|
Gastroenterology
|
2003
|
1.05
|
|
8
|
Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
|
Bull Cancer
|
2006
|
1.02
|
|
9
|
Value of CT enteroclysis in suspected small-bowel carcinoid tumors.
|
AJR Am J Roentgenol
|
2010
|
0.99
|
|
10
|
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
|
Eur J Cancer
|
2009
|
0.99
|
|
11
|
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
|
Eur J Endocrinol
|
2013
|
0.97
|
|
12
|
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
|
Eur J Cancer
|
2011
|
0.93
|
|
13
|
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
|
J Hepatol
|
2010
|
0.91
|
|
14
|
Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion.
|
World J Radiol
|
2010
|
0.87
|
|
15
|
Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors.
|
Am J Infect Control
|
2012
|
0.87
|
|
16
|
New treatment strategies in advanced neuroendocrine tumours.
|
Dig Liver Dis
|
2011
|
0.86
|
|
17
|
Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
|
Neuroendocrinology
|
2012
|
0.86
|
|
18
|
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study.
|
Int J Biol Markers
|
2011
|
0.86
|
|
19
|
Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases.
|
Eur J Endocrinol
|
2009
|
0.86
|
|
20
|
Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases.
|
J Gastrointest Surg
|
2010
|
0.83
|
|
21
|
Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.
|
Dig Liver Dis
|
2011
|
0.82
|
|
22
|
Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.
|
Am J Surg Pathol
|
2002
|
0.82
|
|
23
|
Primary and secondary liver endocrine tumors: clinical presentation, surgical approach and outcome.
|
Hepatogastroenterology
|
2002
|
0.82
|
|
24
|
Primary acinar cell carcinoma of the liver.
|
Virchows Arch
|
2008
|
0.82
|
|
25
|
Primary malignant solid pseudopapillary tumors of the gastroduodenal area.
|
Clin Res Hepatol Gastroenterol
|
2011
|
0.80
|
|
26
|
Trabectedin for the management of soft-tissue sarcoma.
|
Expert Rev Anticancer Ther
|
2009
|
0.80
|
|
27
|
Primary neuroendocrine tumors of the main pancreatic duct: a rare entity.
|
Virchows Arch
|
2011
|
0.80
|
|
28
|
Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation.
|
Eur Radiol
|
2012
|
0.80
|
|
29
|
Malignant insulinoma: recommendations for characterisation and treatment.
|
Ann Endocrinol (Paris)
|
2013
|
0.80
|
|
30
|
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors.
|
Clin Colorectal Cancer
|
2010
|
0.80
|
|
31
|
Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.
|
Eur J Gastroenterol Hepatol
|
2010
|
0.79
|
|
32
|
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
|
Hum Mol Genet
|
2013
|
0.79
|
|
33
|
Propensity score analysis confirms the independent effect of parenteral nutrition on the risk of central venous catheter-related bloodstream infection in oncological patients.
|
Clin Nutr
|
2012
|
0.78
|
|
34
|
18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.
|
Nucl Med Commun
|
2011
|
0.78
|
|
35
|
Sorafenib-induced bilateral osteonecrosis of femoral heads.
|
J Clin Oncol
|
2009
|
0.78
|
|
36
|
Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
|
Pancreas
|
2013
|
0.77
|
|
37
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.
|
Neuroendocrinology
|
2017
|
0.76
|
|
38
|
Neuroendocrine neoplasms of the jejunum: a heterogeneous group with distinctive proximal and distal subsets.
|
Virchows Arch
|
2013
|
0.76
|
|
39
|
Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation.
|
Ultrasound Med Biol
|
2012
|
0.76
|
|
40
|
Familial adenomatous polyposis and pancreatic cancer.
|
Pancreas
|
2015
|
0.76
|
|
41
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy.
|
Neuroendocrinology
|
2017
|
0.75
|
|
42
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.
|
Neuroendocrinology
|
2017
|
0.75
|
|
43
|
Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors.
|
Invest New Drugs
|
2014
|
0.75
|
|
44
|
Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?
|
Acta Oncol
|
2011
|
0.75
|
|
45
|
Long-term survival after pancreaticoduodenectomy for endocrine tumors of the ampulla of Vater and minor papilla.
|
Pancreas
|
2009
|
0.75
|
|
46
|
[Chemotherapy of neuroendocrine tumors].
|
Rev Prat
|
2002
|
0.75
|
|
47
|
[Amphicrine carcinoma of the pancreas. Report of two cases].
|
Ann Pathol
|
2003
|
0.75
|
|
48
|
A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.
|
Eur J Endocrinol
|
2012
|
0.75
|
|
49
|
[Efficacy of argon plasma electrocoagulation to control bleeding from radiation-induced duodenitis].
|
Gastroenterol Clin Biol
|
2003
|
0.75
|
|
50
|
Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two cases.
|
Eur J Endocrinol
|
2008
|
0.75
|
|
51
|
Obstructing minute primary endocrine tumor of the main pancreatic duct: diagnostic relevance of endoscopic ultrasonography.
|
Pancreas
|
2012
|
0.75
|
|
52
|
[Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
|
Gastroenterol Clin Biol
|
2003
|
0.75
|
|
53
|
Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study.
|
Ann Intern Med
|
2015
|
0.75
|
|
54
|
Well-differentiated endocrine carcinoma of the renal pelvis: report of a case with sustained objective response to octreotide.
|
Pathol Res Pract
|
2008
|
0.75
|
|
55
|
Chemotherapy in Well-Differentiated Pancreatic Neuroendocrine Tumours with Ki-67 ≥10%: Is there a More Effective Antitumor Regimen A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE).
|
Neuroendocrinology
|
2017
|
0.75
|